SpaceX’s $7.8B Q2 Beat Masked a $4.5B Retail Loss Crisis Hiding in Plain Sight

(SeaPRwire) –   By: Logan Pierce
SpaceX’s recent stock bounce looks like a clean win for the company at first glance. The 7.8% weekly gain is on track to snap a four-week slide that erased 33% of its share value. But dig past the headline earnings beat, and a far more troubling picture emerges for everyday retail investors who piled into the stock in the months after its IPO. This bounce isn’t a sign that the company’s woes are over—it’s a distraction from the massive losses hanging over small investors who bought in at inflated prices.

The hard numbers from SpaceX’s Q2 report are unassailable on paper. Revenue hit $7.8 billion, a 92% year-over-year jump that beat Wall Street’s $6.8 billion forecast. EBITDA came in at $3.5 billion, more than doubling the consensus estimate of $2.1 billion. The stock closed Friday at around $116.82, roughly 15% below its $135 IPO price, and down 50% from its $225.64 peak earlier this year. Even with the recent bounce, the stock has yet to reclaim its initial public offering price for most investors.

Retail investors bore the brunt of the post-IPO slide, per available data from JPMorgan. They received 20% of SpaceX’s record IPO share allotment, and kept buying in the eight-plus weeks following the public offering. JPMorgan’s data shows retail inflows of at least $3.6 billion during that post-IPO window. With an average purchase price of around $150 per share, that group now holds combined losses of roughly $4.5 billion. Institutional investors, by contrast, offloaded their shares at higher prices to avoid the worst of the drawdown.

Analyst ratings have shifted sharply positive in the wake of the stronger-than-expected Q2 report. Argus upgraded SpaceX stock to Buy from Hold, setting a $160 price target based on a 20x multiple to its 2027 revenue estimate of $110 billion. The firm flagged rapid payback on capital expenditures, mostly tied to AI infrastructure, as a key positive driver of future growth. Other firms have weighed in with even more bullish calls: Raymond James reiterated a Strong Buy with an $800 price target, Bernstein raised its target to $248, and Cantor Fitzgerald kept an Overweight rating at $246. UBS and Mizuho stuck to their Buy and Outperform calls, with targets of $210 and $200 respectively. FactSet data shows analyst 2027 revenue estimates now sit at around $102 billion, up from $72 billion at the end of July.

One major overhang still hangs over SpaceX’s stock price, however. Mizuho pointed out that roughly 911.5 million insider shares are set to become eligible for sale in the near term. Additional tranches of insider shares will become available over the next year, which could keep downward pressure on the share price as more stock hits the public market. SpaceX itself signaled a year-end 2026 revenue run rate approaching $100 billion, well above earlier public forecasts. This forward-looking guidance helped fuel the recent stock bounce, even as the lockup expiration threat looms large over any sustained gains.

Every retail investor who bought SpaceX shares above its IPO price will likely wait years to see a positive return on their investment.

Author bio: Logan Pierce, independent business researcher and corporate governance writer focused on public tech market dynamics on Medium.